We are live on ! Find out more
AA

AlphaCentric Advisors Portfolio holdings

AUM $100M
This Fund
S&P 500
This Quarter Est. Return
-0.63%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$145M
AUM Growth
+$43.7M
Cap. Flow
+$49.2M
Cap. Flow %
33.95%
Top 10 Hldgs %
24.02%
Holding
223
New
58
Increased
36
Reduced
83
Closed
14

Sector Composition

Rank Sector Weight
1 Healthcare 56.03%
2 Real Estate 10.47%
3 Financials 4.37%
4 Energy 4.28%
5 Technology 3.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DDOG icon
201
Datadog
DDOG
$92.1B
$34.4K 0.02%
474
-26
-5% -$1.91K
THD icon
202
iShares MSCI Thailand ETF
THD
$361M
$23.7K 0.02%
+323
New +$24.4K
EPHE icon
203
iShares MSCI Philippines ETF
EPHE
$129M
$7.79K 0.01%
+289
New +$7.98K
AIRS icon
204
AirSculpt Technologies
AIRS
$314M
-360,000
Closed -$1.33M
AME icon
205
Ametek
AME
$54.3B
-7,500
Closed -$1.05M
AVAH icon
206
Aveanna Healthcare
AVAH
$2.11B
-842,000
Closed -$657K
EMBC icon
207
Embecta
EMBC
$193M
-5,000
Closed -$126K
GMED icon
208
Globus Medical
GMED
$10.5B
-10,000
Closed -$743K
MQY icon
209
BlackRock MuniYield Quality Fund
MQY
$828M
-10,000
Closed -$116K
PBYI icon
210
Puma Biotechnology
PBYI
$434M
-50,000
Closed -$212K
PFSI icon
211
PennyMac Financial
PFSI
$4.43B
-31,123
Closed -$1.76M
STWD icon
212
Starwood Property Trust
STWD
$6.3B
-65,000
Closed -$1.19M
VUZI icon
213
Vuzix
VUZI
$188M
-150,000
Closed -$546K
ZYME icon
214
Zymeworks
ZYME
$1.78B
-52,500
Closed -$413K
MRTX
215
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
-14,000
Closed -$634K
CINC
216
DELISTED
CinCor Pharma, Inc. Common Stock
CINC
-70,000
Closed -$860K
SAFE
217
DELISTED
Safehold Inc.
SAFE
-3,874
Closed -$111K

Similar funds

AlphaCentric Advisors's Q1 2023 Portfolio in Review

As of Q1 2023, AlphaCentric Advisors held 223 positions worth $145M, up 43% from $101M the previous quarter. Its ten largest holdings account for 24% of the portfolio.

AlphaCentric Advisors deployed $49.2M of net new capital in Q1 2023, opening 58 new positions and adding to 36 existing holdings. Its largest new stake was iShares 1-3 Year Treasury Bond ETF: 76,992 shares worth $6.33M.

By sector, the portfolio is most concentrated in Healthcare at 56% of assets, down from 57% a quarter earlier, followed by Real Estate and Financials.

On the sell side, the largest reduction was Aurinia Pharmaceuticals, an estimated $2.42M trimmed.

  • AlphaCentric Advisors's largest Q1 2023 buy was iShares 1-3 Year Treasury Bond ETF: 76,992 shares worth $6.33M.
  • AlphaCentric Advisors added most to BioCryst Pharmaceuticals in Q1 2023, an estimated $2.84M increase.
  • AlphaCentric Advisors's biggest Q1 2023 reduction was Aurinia Pharmaceuticals, cutting an estimated $2.42M.
  • AlphaCentric Advisors fully exited PennyMac Financial in Q1 2023, selling an estimated $1.76M.
  • AlphaCentric Advisors's ten largest holdings make up 24% of its $145M portfolio in Q1 2023.
  • AlphaCentric Advisors opened 58 new positions and closed 14 in Q1 2023.
  • AlphaCentric Advisors's portfolio value rose 43% quarter-over-quarter to $145M.

Based on AlphaCentric Advisors's 13F filing for Q1 2023, filed 12 May 2023.